0.38
-8.41%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About cbdMD
From its filings with the US Securities and Exchange Commission
cbdMD is based in Charlotte, North Carolina and is incorporated in North Carolina. Its shares trade on NYSE under the ticker YCBD. The SEC classifies its business as perfumes, cosmetics & other toilet preparations. In the fiscal year to 30 September 2025, it reported revenue of $19.2m and a net loss of $2.0m. At that date it held total assets of $10.4m and shareholders' equity of $7.2m.
We operate a multi-brand portfolio anchored by our flagship cbdMD® line, which offers oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. Complementing this portfolio is Paw CBD®, our dedicated pet-wellness brand, which provides tinctures, chews, and topicals for dogs and cats and reflects our long-standing emphasis on safety and quality in the animal health category.
Our ATRX® platform offers cutting edge, emerging and novel non-cannabinoid functional ingredients such as functional mushrooms and supports future expansion into performance-driven nutraceutical and nootropic categories utilizing synergistic ingredient combinations.
Our Herbal Oasis (“Oasis”) brand is a premium hemp-derived THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to deliver a fast-acting, functional beverage made for presence and connection.
Our products are sold through a diversified distribution network that includes direct-to-consumer e-commerce platforms, online marketplaces, wholesale distribution to national and regional retailers, specialty health and pet channels, and emerging international markets. This multi-channel strategy allows us to reach a broad and diverse consumer base, reduce reliance on any single distribution partner, and quickly introduce new products which reflect scientific findings, consumer trends, and regulatory dynamics.
Quoted from its 10-K, filed 19 Dec 2025. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 17 Nov 2017
- Employees
- 42
- Website
- levelbrands.com ↗
- Head office
- 8845 RED OAK BOULEVARD, CHARLOTTE, NC, 28217
- Incorporated in
- NC
- Classification
- Perfumes, Cosmetics & Other Toilet Preparations
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Scott StephenIndependent Chairman of the Board$74,514
- Mr. T. Ronan KennedyChief Executive Officer, Chief Financial Officer, Director, since 2020$275,000
- Mr. Bradley WhitfordChief Accounting Officer, Treasurer, Company Secretary$181,375
- Dr. Sibyl SwiftChief Science Officer, Vice President - Scientific and Regulatory Affairs, Director, since 2021$4,514
- Mr. William RainesIndependent Director$60,514
- Mr. Bakari SellersIndependent Director$55,014
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 26
- Environment
- 1
- Social
- 21
- Governance
- 56
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- cbdMD's CBD gummies and tinctures are popular in the US market.
- The company has a strong presence in the Health Care sector with 182 employees.
- cbdMD's CBD pet products are gaining traction in the US consumer segment.
Weaknesses
- cbdMD has only 42 employees in the US, which is low for its sector.
- The company's product range is limited to CBD categories only.
- cbdMD's IPO in 2017 has not expanded its market reach significantly.
Opportunities
- cbdMD can expand its CBD bath bombs into the European market.
- The growing demand for CBD topicals in the US offers new opportunities.
- cbdMD can leverage its 182 employees to enter the Information Technology sector.
Threats
- cbdMD faces competition from other US-based CBD companies.
- Regulatory changes in the US Health Care sector could impact operations.
- The limited product range may not meet future market demands.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.